255 related articles for article (PubMed ID: 9453600)
1. Lactoferrin inhibits the endotoxin interaction with CD14 by competition with the lipopolysaccharide-binding protein.
Elass-Rochard E; Legrand D; Salmon V; Roseanu A; Trif M; Tobias PS; Mazurier J; Spik G
Infect Immun; 1998 Feb; 66(2):486-91. PubMed ID: 9453600
[TBL] [Abstract][Full Text] [Related]
2. Lactoferrin-lipopolysaccharide interaction: involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide.
Elass-Rochard E; Roseanu A; Legrand D; Trif M; Salmon V; Motas C; Montreuil J; Spik G
Biochem J; 1995 Dec; 312 ( Pt 3)(Pt 3):839-45. PubMed ID: 8554529
[TBL] [Abstract][Full Text] [Related]
3. 3LPS-binding protein and its interactions with P. gingivalis LPS modulate pro-inflammatory response and Toll-like receptor signaling in human oral keratinocytes.
Ding PH; Darveau RP; Wang CY; Jin L
PLoS One; 2017; 12(4):e0173223. PubMed ID: 28384159
[TBL] [Abstract][Full Text] [Related]
4. Human lactoferrin interacts with soluble CD14 and inhibits expression of endothelial adhesion molecules, E-selectin and ICAM-1, induced by the CD14-lipopolysaccharide complex.
Baveye S; Elass E; Fernig DG; Blanquart C; Mazurier J; Legrand D
Infect Immun; 2000 Dec; 68(12):6519-25. PubMed ID: 11083760
[TBL] [Abstract][Full Text] [Related]
5. Cross-linking of lipopolysaccharide (LPS) to CD14 on THP-1 cells mediated by LPS-binding protein.
Tobias PS; Soldau K; Kline L; Lee JD; Kato K; Martin TP; Ulevitch RJ
J Immunol; 1993 Apr; 150(7):3011-21. PubMed ID: 7681085
[TBL] [Abstract][Full Text] [Related]
6. Bactericidal/permeability-increasing protein and lipopolysaccharide (LPS)-binding protein. LPS binding properties and effects on LPS-mediated cell activation.
Wilde CG; Seilhamer JJ; McGrogan M; Ashton N; Snable JL; Lane JC; Leong SR; Thornton MB; Miller KL; Scott RW
J Biol Chem; 1994 Jul; 269(26):17411-6. PubMed ID: 7517398
[TBL] [Abstract][Full Text] [Related]
7. Lipopolysaccharide-binding protein down-regulates the expression of interleukin-6 by human gingival fibroblast.
Ren L; Leung WK; Loo TW; Jin L
J Periodontal Res; 2005 Oct; 40(5):407-16. PubMed ID: 16105094
[TBL] [Abstract][Full Text] [Related]
8. The carboxyl-terminal domain of closely related endotoxin-binding proteins determines the target of protein-lipopolysaccharide complexes.
Iovine N; Eastvold J; Elsbach P; Weiss JP; Gioannini TL
J Biol Chem; 2002 Mar; 277(10):7970-8. PubMed ID: 11773072
[TBL] [Abstract][Full Text] [Related]
9. Competition between bactericidal/permeability-increasing protein and lipopolysaccharide-binding protein for lipopolysaccharide binding to monocytes.
Heumann D; Gallay P; Betz-Corradin S; Barras C; Baumgartner JD; Glauser MP
J Infect Dis; 1993 Jun; 167(6):1351-7. PubMed ID: 8501324
[TBL] [Abstract][Full Text] [Related]
10. Directed evolution of an LBP/CD14 inhibitory peptide and its anti-endotoxin activity.
Fang L; Xu Z; Wang GS; Ji FY; Mei CX; Liu J; Wu GM
PLoS One; 2014; 9(7):e101406. PubMed ID: 25025695
[TBL] [Abstract][Full Text] [Related]
11. Transfection of CD14 into 70Z/3 cells dramatically enhances the sensitivity to complexes of lipopolysaccharide (LPS) and LPS binding protein.
Lee JD; Kato K; Tobias PS; Kirkland TN; Ulevitch RJ
J Exp Med; 1992 Jun; 175(6):1697-705. PubMed ID: 1375269
[TBL] [Abstract][Full Text] [Related]
12. High concentrations of lipopolysaccharide-binding protein in serum of patients with severe sepsis or septic shock inhibit the lipopolysaccharide response in human monocytes.
Zweigner J; Gramm HJ; Singer OC; Wegscheider K; Schumann RR
Blood; 2001 Dec; 98(13):3800-8. PubMed ID: 11739189
[TBL] [Abstract][Full Text] [Related]
13. Evidence of a trimolecular complex involving LPS, LPS binding protein and soluble CD14 as an effector of LPS response.
Thomas CJ; Kapoor M; Sharma S; Bausinger H; Zyilan U; Lipsker D; Hanau D; Surolia A
FEBS Lett; 2002 Nov; 531(2):184-8. PubMed ID: 12417309
[TBL] [Abstract][Full Text] [Related]
14. Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids.
Yu B; Hailman E; Wright SD
J Clin Invest; 1997 Jan; 99(2):315-24. PubMed ID: 9006000
[TBL] [Abstract][Full Text] [Related]
15. Surfactant protein a inhibits lipopolysaccharide-induced immune cell activation by preventing the interaction of lipopolysaccharide with lipopolysaccharide-binding protein.
Stamme C; Müller M; Hamann L; Gutsmann T; Seydel U
Am J Respir Cell Mol Biol; 2002 Sep; 27(3):353-60. PubMed ID: 12204898
[TBL] [Abstract][Full Text] [Related]
16. An amino-terminal fragment of human lipopolysaccharide-binding protein retains lipid A binding but not CD14-stimulatory activity.
Theofan G; Horwitz AH; Williams RE; Liu PS; Chan I; Birr C; Carroll SF; Mészáros K; Parent JB; Kasler H
J Immunol; 1994 Apr; 152(7):3623-9. PubMed ID: 7511654
[TBL] [Abstract][Full Text] [Related]
17. Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway.
Kitchens RL; Ulevitch RJ; Munford RS
J Exp Med; 1992 Aug; 176(2):485-94. PubMed ID: 1380063
[TBL] [Abstract][Full Text] [Related]
18. Lipopolysaccharide (LPS) binding protein, truncated at Ile-197, binds LPS but does not transfer LPS to CD14.
Han J; Mathison JC; Ulevitch RJ; Tobias PS
J Biol Chem; 1994 Mar; 269(11):8172-5. PubMed ID: 7510680
[TBL] [Abstract][Full Text] [Related]
19. Function of lipopolysaccharide (LPS)-binding protein (LBP) and CD14, the receptor for LPS/LBP complexes: a short review.
Schumann RR
Res Immunol; 1992 Jan; 143(1):11-5. PubMed ID: 1373512
[TBL] [Abstract][Full Text] [Related]
20. Lipopolysaccharide stimulates HepG2 human hepatoma cells in the presence of lipopolysaccharide-binding protein via CD14.
Nanbo A; Nishimura H; Muta T; Nagasawa S
Eur J Biochem; 1999 Feb; 260(1):183-91. PubMed ID: 10091598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
